Trial intelligence / Profile preview

Oliceridine versus remifentanil versus saline for analgesia during vertebroplasty/kyphoplasty under local anesthesia in osteoporotic vertebral fractures

ChiCTR2400095085Phase 4Not yet recruiting

Sponsor
Ningde Mindong Hospital
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of oliceridine in vertebral compression fracture (VCF) (3 arms), sponsored by Ningde Mindong Hospital. Primary endpoint: Pain VAS score. Planned start Dec 2024; status: not yet recruiting.

02

Drugs

oliceridine
03

Conditions

vertebral compression fracture (VCF)

Beyond the preview

Go deeper on ChiCTR2400095085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400095085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call